Key Takeaways From Establishment Labs Hldgs Analyst Ratings

In the preceding three months, 4 analysts have released ratings for Establishment Labs Hldgs ESTA, presenting a wide array of perspectives from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

Analysts have recently evaluated Establishment Labs Hldgs and provided 12-month price targets. The average target is $56.25, accompanied by a high estimate of $65.00 and a low estimate of $47.00. Witnessing a positive shift, the current average has risen by 15.57% from the previous average price target of $48.67.

Investigating Analyst Ratings: An Elaborate Study

In examining recent analyst actions, we gain insights into how financial experts perceive Establishment Labs Hldgs. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Establishment Labs Hldgs. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Establishment Labs Hldgs compared to the broader market.
• Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Establishment Labs Hldgs's stock. This comparison reveals trends in analysts' expectations over time.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Establishment Labs Hldgs's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Establishment Labs Hldgs analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

All You Need to Know About Establishment Labs Hldgs

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Establishment Labs Hldgs: Delving into Financials

Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.

Negative Revenue Trend: Examining Establishment Labs Hldgs's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately -27.97% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Establishment Labs Hldgs's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -65.09%, the company may encounter challenges in effective cost control.

Return on Equity (ROE): Establishment Labs Hldgs's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -84.05%, the company may face hurdles in generating optimal returns for shareholders.

Return on Assets (ROA): Establishment Labs Hldgs's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -7.62%, the company may face hurdles in generating optimal returns from its assets.

Debt Management: Establishment Labs Hldgs's debt-to-equity ratio stands notably higher than the industry average, reaching 10.45. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.

How Are Analyst Ratings Determined?

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

This article was generated by Benzinga's automated content engine and reviewed by an editor.